Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Deloitte
Medtronic
Mallinckrodt
Cipla
Citi
Accenture
Colorcon

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIENOGEST; ESTRADIOL VALERATE

« Back to Dashboard

Clinical Trials for Dienogest; Estradiol Valerate

Trial ID Title Status Sponsor Phase Summary
NCT00293059 Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Completed Bayer Phase 3 The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
NCT00307801 Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Completed Bayer Phase 3 The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
NCT00335218 Fat Distribution in Healthy Early Postmenopausal Women Completed Bayer Phase 4 The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.
NCT00764881 Effects of SH T00658ID on Libido Completed Bayer Phase 3 The aim of the study is to investigate whether women on oral contraceptives (OCs) suffering from acquired OC-associated female sexual dysfunction (FSD) for at least 3 months but no longer than one year will express the same level of sexual distress when taking SH T00658ID compared to Microgynon, the usual OC prescribed for women with OC-associated FSD.
NCT00778609 Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache Completed Bayer Phase 3 The aim of the present study is to investigate whether women taking a new combined oral contraceptive pill (SH T00658ID, estradiol valerate/dienogest) experience fewer hormone withdrawal-associated symptoms such as pelvic pain or headache during their monthly cycle compared to a commonly used contraceptive pill (Microgynon).
NCT00805415 Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens Completed Bayer Phase 2 The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dienogest; Estradiol Valerate

Condition Name

Condition Name for Dienogest; Estradiol Valerate
Intervention Trials
Contraception 4
Metrorrhagia 3
Pharmacology, Clinical 1
Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dienogest; Estradiol Valerate
Intervention Trials
Metrorrhagia 3
Hemorrhage 3
Uterine Hemorrhage 2
Dysmenorrhea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dienogest; Estradiol Valerate

Trials by Country

Trials by Country for Dienogest; Estradiol Valerate
Location Trials
China 20
United States 20
Germany 18
Australia 11
United Kingdom 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dienogest; Estradiol Valerate
Location Trials
North Carolina 1
Virginia 1
Ohio 1
Oregon 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dienogest; Estradiol Valerate

Clinical Trial Phase

Clinical Trial Phase for Dienogest; Estradiol Valerate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 6
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dienogest; Estradiol Valerate
Clinical Trial Phase Trials
Completed 11
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dienogest; Estradiol Valerate

Sponsor Name

Sponsor Name for Dienogest; Estradiol Valerate
Sponsor Trials
Bayer 10
Estetra 1
Adana Numune Training and Research Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dienogest; Estradiol Valerate
Sponsor Trials
Industry 11
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Accenture
Cantor Fitzgerald
Dow
Daiichi Sankyo
Baxter
McKesson
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.